Literature DB >> 9477394

Effects of captopril and enalapril on zinc metabolism in hypertensive patients.

A Golik1, R Zaidenstein, V Dishi, A Blatt, N Cohen, G Cotter, S Berman, J Weissgarten.   

Abstract

OBJECTIVE: To investigate the effect of chronic captopril and enalapril treatment on zinc metabolism in hypertensive patients by assessing zinc levels in serum, urine and monocytes.
METHODS: Patients with newly diagnosed essential hypertension were randomly divided into two treatment groups: those treated with captopril only (n = 16) and those treated with enalapril only (n = 18). Ten healthy subjects served as controls. Prior to the start of treatment and again 6 months later, zinc was assessed in the serum, in urine collected over 24 hours, and in peripheral blood monocytes.
RESULTS: Significant enhancement of 24-hour urinary zinc excretion (micrograms/24 hour) after 6 months of treatment was observed only in the captopril-treated group (p < 0.01). However, intramonocytic zinc levels decreased significantly in both of the treated groups over the same period (p < 0.01 and P < 0.04 in the captopril- and enalapril-treated groups, respectively).
CONCLUSION: Treatment of hypertensive patients with captopril or enalapril may result in zinc deficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9477394     DOI: 10.1080/07315724.1998.10720459

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  15 in total

1.  Congestive heart failure: where homeostasis begets dyshomeostasis.

Authors:  German Kamalov; Syamal K Bhattacharya; Karl T Weber
Journal:  J Cardiovasc Pharmacol       Date:  2010-09       Impact factor: 3.105

2.  Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics.

Authors:  Nikhil H Gokhale; J A Cowan
Journal:  J Biol Inorg Chem       Date:  2006-07-28       Impact factor: 3.358

Review 3.  Micronutrients and their supplementation in chronic cardiac failure. An update beyond theoretical perspectives.

Authors:  Klaus K Witte; Andrew L Clark
Journal:  Heart Fail Rev       Date:  2006-03       Impact factor: 4.214

Review 4.  Disturbances in calcium metabolism and cardiomyocyte necrosis: the role of calcitropic hormones.

Authors:  Jawwad Yusuf; M Usman Khan; Yaser Cheema; Syamal K Bhattacharya; Karl T Weber
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

5.  Intracellular calcium overloading and oxidative stress in cardiomyocyte necrosis via a mitochondriocentric signal-transducer-effector pathway.

Authors:  Mazen Shaheen; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Exp Clin Cardiol       Date:  2011

6.  Dietary Sodium Intake is Predicted by Antihypertensive Medication Regimen in Patients With Heart Failure.

Authors:  Jennifer L Smith; Terry A Lennie; Misook L Chung; Gia Mudd-Martin
Journal:  J Cardiovasc Nurs       Date:  2019 Jul/Aug       Impact factor: 2.083

Review 7.  Cellular and molecular pathways to myocardial necrosis and replacement fibrosis.

Authors:  Malay S Gandhi; German Kamalov; Atta U Shahbaz; Syamal K Bhattacharya; Robert A Ahokas; Yao Sun; Ivan C Gerling; Karl T Weber
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

8.  Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Authors:  Brian J Borkowski; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

9.  Nutrition in Pediatric Cardiomyopathy.

Authors:  Tracie L Miller; Daniela Neri; Jason Extein; Gabriel Somarriba; Nancy Strickman-Stein
Journal:  Prog Pediatr Cardiol       Date:  2007-11

Review 10.  Mineralocorticoid receptor antagonism confers cardioprotection in heart failure.

Authors:  Michael R Seawell; Fahed Al Darazi; Victor Farah; Kodangudi B Ramanathan; Kevin P Newman; Syamal K Bhattacharya; Karl T Weber
Journal:  Curr Heart Fail Rep       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.